Genetic Variations in the KCNJ5 Gene in Primary Aldosteronism Patients from Xinjiang, China

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Li, Nan Fang ^a   Li, Hong Jian ^b   Zhang, De Lian ^a   Zhang, Ju Hong ^a   Yao, Xiao Guang ^a   Wang, Hong Mei ^a   Abulikemu, Suofeiya ^a   Zhou, Ke Ming ^a   Zhang, Xiang Yang ^b  

^a The Center of Hypertension of the People's Hospital of Xinjiang Uygur Autonomous Region   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KCNJ5 GENE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIMARY HYPERALDOSTERONISM; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CHINA; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENETIC ASSOCIATION STUDIES; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84873129212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054051     Document Type: Article

References (31)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, et al. (2008) Endocrine Society Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281.
2. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, et al. (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168: 80-85.
3. Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, et al. (2005) Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab. 90: 5070-5076.
4. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, et al. (2006) Long-term renal outcomes in patients with primary aldosteronism. JAMA 295: 2638-2645.
5. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, et al. (2006) Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 48: 232-238.
6. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, et al. (2009) Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism:results of the German Conn's registry. J Clin Endocrinol Metab 94: 1125-1130.
7. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, et al. (2008) TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci USA 105: 2203-2208.
8. Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, et al. (2008) Invalidation of TASK1 potassiumchannels disrupts adrenal gland zonation and mineralocorticoid homeostasis. Embo J 27: 179-187.
9. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, et al. (2010) Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles. Physiol Rev 90: 291-366.
10. Dascal N, Schreibmayer W, Lim NF, Wang W, Chavkin C, et al. (1993) Atrial Gprotein-activated K+channel: expression cloning and molecular properties. Proc Natl Acad Sci USA 90: 10235-10239.
11. Krapivinsky G, Gordon EA, Wickman K, Velimirović B, Krapivinsky L, et al. (1995) The G-protein-gated atrial K+channel I KAch is a heteromultimer of two inwardly rectifying K+-channel proteins. Nature 374: 135-141.
12. Corey S, Clapham DE, (1998) Identification of native atrial G-protein-regulated inwardly rectifying K+(GIRK4) channel homomultimers.J Biol Chem. 273: 499-504.
13. Zhang C, Yuan G, Cheng Z, Xu M, Hou L, et al. (2009) The single nucleotide polymorphisms of Kir3.4 gene and their correlation with lone paroxysmal atrial fibrillation in Chinese Han population. Heart Lung Circ 18: 257-261.
14. Jabbari J, Olesen MS, Holst AG, Nielsen JB, Haunso S, et al. (2011) Common polymorphisms in KCNJ5 are associated with early-onset lone atrial fibrillation in Caucasians. Cardiology 118: 116-120.
15. Choi M, Scholl UI, Yue P, Björklund P, Zhao B, et al. (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331: 768-772.
16. Mulatero P, Tauber P, Zennaro MC, Monticone S, Lang K, et al. (2012) KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism. Hypertension 59: 235-240.
17. Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, et al. (2012) Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism. Hypertension 59: 592-598.
18. Azizan EA, Murthy M, Stowasser M, Gordon R, Kowalski B, et al. (2012) Somatic Mutations Affecting the Selectivity Filter of KCNJ5 Are Frequent in 2 Large Unselected Collections of Adrenal Aldosteronomas. Hypertension 59: 587-591.
19. Taguchi R, Yamada M, Nakajima Y, Satoh T, Hashimoto K, et al. (2012) Expression and Mutations of KCNJ5 mRNA in Japanese Patients with Aldosterone-Producing Adenomas. J Clin Endocrinol Metab 97: 1311-1319.
20. Tiu SC, Choi CH, Shek CC, Ng YW, Chan FKW, et al. (2005) The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling. J Clin Endocrinol Metab 90: 72-78.
21. Li N, Zhang D, Zhang J, Guo Y, Yan Z, et al. (2012) Influence of age on the association of GIRK4 with metabolic syndrome. Ann Clin Biochem 49: 369-376.
22. Li N, Luo W, Juhong Z, Yang J, Wang H, et al. (2010) Associations between genetic variations in the FURIN gene and hypertension. BMC Medical Genetics 11: 124.
23. Shimodaira M, Nakayama T, Sato N, Aoi N, Sato M, et al. (2010) Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure. Eur J Endocrinol 163: 671-680.
24. Murthy M, Azizan EA, Brown MJ, O'Shaughnessy KM, (2012) Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma. J Hypertens 30: 1827-1833.
25. Åkerström T, Crona J, Delgado Verdugo A, Starker LF, Cupisti K, et al. (2012) Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLOS One 7: e41926.
26. Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, et al. (2012) Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.Proc Natl Acad Sci USA. 109: 2533-2538.
27. Fabian MR, Sonenberg N, Filipowicz W, (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
28. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, et al. (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708.
29. Kedde M, Strasser MJ, Boldajipour B, Oude Vrielink JA, Slanchev K, et al. (2007) RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131: 1273-1286.
30. Gomez-Benito M, Loayza-Puch F, Oude Vrielink JA, Odero MD, Agami R, (2011) 3′UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) gene. PLOS One 6: e25449.
31. Mayr C, Bartel DP, (2009) Widespread shortening of 3′UTR by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.